PlexPress raises $2.8M to enhance gene expression
PlexPress, maker of technology that can measure which genes are being expressed and how in a given environment, has raised $2.75 million in seed funding to commercialize its lead product, called TRAC. Based in Los Altos, Calif., the company says this offering could rapidly accelerate certain types of genetic research, including diagnostic studies and drug development. And because it simplifies laboratory procedures, it could even cut costs.
The round of funding came from Conor Technology Fund, Veraventure, Helsinki University Fund and VTT. PlexPress says the market for products like TRAC should hit $1 billion in the next four years, making it a ripe investment opportunity now.
Next Story: Sustainable Energy catches $7.6M for solar inverters
Previous Story: Google Searchology: Search options, Google Squared and more
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.